Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator Mortgage Calculator

Compound Interest Calculator Dollar Cost Averaging

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

TOOLS

Earnings Calendar

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Coherus Biosciences (CHRS)

NASDAQ:CHRS

CHRS

Coherus Biosciences

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Coherus Biosciences (CHRS) Stock News & Sentiment

1,208 Followers

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

PremiumPress Releases

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

2d ago

Coherus data show CHS-1000 acts to reverse myeloid suppression

PremiumThe Fly

Coherus data show CHS-1000 acts to reverse myeloid suppression

18d ago

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting

PremiumPress Releases

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting

18d ago

Coherus Biosciences price target lowered to $11 from $13 at H.C. Wainwright

PremiumThe Fly

Coherus Biosciences price target lowered to $11 from $13 at H.C. Wainwright

1M ago

Coherus Biosciences reports Q4 EPS (62c), consensus (12c)

PremiumThe Fly

Coherus Biosciences reports Q4 EPS (62c), consensus (12c)

1M ago

Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update

PremiumPress Releases

Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update

1M ago

Coherus BioSciences options imply 21.5% move in share price post-earnings

PremiumThe Fly

Coherus BioSciences options imply 21.5% move in share price post-earnings

1M ago

More CHRS News >

CHRS News on the Web

2024-04-11

Investors in Coherus BioSciences have unfortunately lost 83% over the last five years

Yahoo Finance

Neutral

2024-04-08

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting

Yahoo Finance

Neutral

2024-03-15

Coherus Biosciences Inc (CHRS) is higher by 3.23% Friday In Premarket Trading

Investors Observer

Neutral

2024-03-15

Coherus BioSciences Full Year 2023 Earnings: EPS Misses Expectations

Yahoo Finance

Neutral

2024-03-15

Coherus Biosciences: Strong Q4 Performance and Strategic Moves Merit Outperform Rating

TipRanks News

Bullish

2024-03-15

Analysts Offer Insights on Healthcare Companies: Coherus Biosciences (CHRS) and Solid Biosciences (SLDB)

TipRanks News

Bullish

2024-03-14

Why Coherus Biosciences Stock Tumbled on Thursday

Motley Fool

Bearish

2024-03-14

Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Coherus Biosciences (CHRS) and Autolus Therapeutics (AUTL)

TipRanks News

Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CHRS’s Media Buzz Sentiment?

Currently, no data Available

What is CHRS’s weekly average amount of articles?

Currently, no data Available

What is CHRS’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

IMVTImmunovant

RVVRevive Therapeutics

NVSNovartis

ISRGIntuitive Surgical

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing